Russia Defence Forum

Would you like to react to this message? Create an account in a few clicks or log in to continue.

Military Forum for Russian and Global Defence Issues


+35
Rasisuki Nebia
UZB-76
Arrow
Backman
lancelot
Big_Gazza
mnztr
Kiko
Nomad5891
lyle6
Scorpius
owais.usmani
PapaDragon
flamming_python
limb
Walther von Oldenburg
LMFS
GarryB
kvs
SeigSoloyvov
par far
Hole
calripson
PhSt
George1
Regular
miketheterrible
Project Canada
SKALA.Medica
higurashihougi
sepheronx
magnumcromagnon
AlfaT8
NationalRus
KomissarBojanchev
39 posters

    Russian Medical Development: News

    Kiko
    Kiko


    Posts : 931
    Points : 949
    Join date : 2020-11-11
    Age : 72
    Location : Brasilia

    Russian Medical Development: News - Page 16 Empty Re: Russian Medical Development: News

    Post  Kiko Fri Nov 12, 2021 9:11 pm

    Coronavirus drug registered in Russia

    The first injectable drug for the treatment of COVID-19 "Areplivir" was registered in Russia.

    MOSCOW, November 12 - RIA Novosti. A drug for the coronavirus "Areplivir" has been registered in Russia , follows from the state register of medicines.

    "Date of registration: 11/12/2021. It is allowed to enter into civil circulation up to five years," - follows from the drug card.
    The drug for coronavirus infection "Areplivir" (international non-proprietary name "Favipiravir") was developed and produced at the Saransk plant "Biochemist" (part of the " Promomed " group ) in 2020.

    In February 2021, the Ministry of Industry and Trade reported that since September the plant has increased the production of the drug tenfold, to one million packs per month, and plans to increase production to two million.

    "Areplivir" is included in the methodological recommendations of the Ministry of Health for the treatment of coronavirus infection and is included in the list of vital and essential medicines. In addition, its outpatient use is permitted. The recommended price is 5060 rubles.

    https://ria.ru/20211112/preparat-1758845780.html

    kvs and Hole like this post

    GarryB
    GarryB


    Posts : 31502
    Points : 32032
    Join date : 2010-03-30
    Location : New Zealand

    Russian Medical Development: News - Page 16 Empty Re: Russian Medical Development: News

    Post  GarryB Sat Nov 13, 2021 10:17 am

    So recommended price is about $70 US dollars.... or $700,000 if it ever reaches the west...

    Pretty good price for something that will only be used when it is needed... ie sick patients in hospital that already have covid would use this... $70 to inject this and quickly free up a bed is good value for money...

    dino00 likes this post

    avatar
    owais.usmani


    Posts : 910
    Points : 908
    Join date : 2019-03-27
    Age : 35

    Russian Medical Development: News - Page 16 Empty Re: Russian Medical Development: News

    Post  owais.usmani Tue Nov 16, 2021 10:17 am

    https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-conduct-trials-antiviral-covid-19-pill-russia-2021-11-16/

    MOSCOW, Nov 16 (Reuters) - Russia has granted approval for Pfizer Inc (PFE.N) to conduct clinical trials in Russia of its experimental antiviral pill to treat COVID-19, a state registry of medicines showed on Tuesday.

    The trials conducted on 90 people located in home-like conditions with someone who has symptomatic COVID-19 began on Nov. 12 and will continue until March 2023, the registry's website said.

    Pfizer said earlier this month the experimental antiviral pill cut by 89% the chance of hospitalisation or death for adults at risk of severe disease. It hopes to make the pill available globally as quickly as possible. read more

    The pill has the brand name Paxlovid.

    kvs and PapaDragon like this post

    JohninMK
    JohninMK


    Posts : 9520
    Points : 9635
    Join date : 2015-06-16
    Location : England

    Russian Medical Development: News - Page 16 Empty Re: Russian Medical Development: News

    Post  JohninMK Tue Nov 16, 2021 5:00 pm

    owais.usmani wrote:https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-conduct-trials-antiviral-covid-19-pill-russia-2021-11-16/

    MOSCOW, Nov 16 (Reuters) - Russia has granted approval for Pfizer Inc (PFE.N) to conduct clinical trials in Russia of its experimental antiviral pill to treat COVID-19, a state registry of medicines showed on Tuesday.

    The trials conducted on 90 people located in home-like conditions with someone who has symptomatic COVID-19 began on Nov. 12 and will continue until March 2023, the registry's website said.

    Pfizer said earlier this month the experimental antiviral pill cut by 89% the chance of hospitalisation or death for adults at risk of severe disease. It hopes to make the pill available globally as quickly as possible. read more

    The pill has the brand name Paxlovid.

    This looks like Pfizermectin is coming to Russia.

    PapaDragon likes this post

    Kiko
    Kiko


    Posts : 931
    Points : 949
    Join date : 2020-11-11
    Age : 72
    Location : Brasilia

    Russian Medical Development: News - Page 16 Empty Re: Russian Medical Development: News

    Post  Kiko Tue Nov 16, 2021 9:37 pm

    Mir-19 medication effective against all coronavirus strains, Russian official says, 16/11/2021.

    Phase one clinical trials had confirmed that the nasal form of the medication was well-tolerated, Head of Russia’s Federal Medical-Biological Agency Veronika Skvortsova notes.

    MOSCOW, November 16. /TASS/. The Mir-19 anti-coronavirus drug is capable of blocking the viral replication site so it is effective against all virus strains, Head of Russia’s Federal Medical-Biological Agency (FMBA) Veronika Skvortsova told the Rossiya-24 TV channel on Tuesday.

    "A medication has been developed that is capable of blocking the replication site of the SARS-Cov-2 virus. The replication site is crucial for the virus, not only for some particular strain but for the entire SARS-Cov-2 lineage, which is why it is a universal solution," she pointed out.

    Skvortsova noted that phase one clinical trials had confirmed that the nasal form of the medication was well-tolerated. "The drug is safe for humans as it only impacts the virus and not the entire body. It is a highly specific aetiotropic antiviral drug," she stressed.

    The Mir-19 medication, designed to prevent and treat coronavirus, is suitable for inhalation and nasal administration. It halts virus replication and prevents the most severe forms of the infection, as well as pneumonitis and the acute respiratory distress syndrome that the infection causes.

    https://tass.com/society/1362237

    GarryB, dino00 and Hole like this post

    Kiko
    Kiko


    Posts : 931
    Points : 949
    Join date : 2020-11-11
    Age : 72
    Location : Brasilia

    Russian Medical Development: News - Page 16 Empty Re: Russian Medical Development: News

    Post  Kiko Mon Nov 22, 2021 6:13 pm

    Russian Exporters Hold Talks During Medical Exhibition in Germany, 22/11/2021.

    Moscow (Sputnik) – Russian exporters of medical equipment held more than 200 meetings to discuss more than $36 million of products at the largest international medical exhibition Medica 2021 in Düsseldorf, the Russian Export Centre (part of VEB.RF Group) reported.

    “From 15 to 18 November the largest international medical exhibition Medica 2021 was held in Düsseldorf, Germany. With the support of REC, 22 Russian companies producing medical products took part in the exhibition. On average, the business potential of one meeting amounted to $172 thousand, while the overall potential of the meetings amounted to more than $36 million,” the REC informed.

    REC traditionally organises targeted meetings with potential buyers for each exporter. “After four days of work of Russian exposition, a total of 207 business meetings have been held at the exhibition,” the REC added.

    As a result of targeted meetings, Russian companies concluded contracts and signed agreements on the delivery of their products to foreign markets. For example, Triton Electronic Systems LTD has signed a supplement to the contract for the amount of 945 thousand euros for the supply of multi-gas monitors. The contract provides for the supply of AMG-06 Anesthesia monitors to EU countries and worldwide through a global European distributor.

    Arrangements have also been made for the future deliveries of intensive care and resuscitation equipment worth 3 million euros over the next two years. Intensive care and resuscitation equipment of Triton Electronic Systems LTD is already supplied to 40 countries. LLC “Medical Biological Union” and the company “First Med” from Egypt have also signed an agreement on delivery of laboratory diagnostic kits, test materials for haematological analysers and standard serum panels to the Egyptian market. LLC “Razvitie” has concluded contracts with Sandor Medicaid’s Pvt. Ltd from India and Echo Medical Supplies from Jordan. Details of the agreement (volumes of deliveries) are under discussion between the parties concerned.

    The same documents have been signed by LLC “Potok Inter” and Sana Klinik Service GmbH (Germany).

    https://sputniknews.com/20211122/russian-exporters-hold-talks-during-medical-exhibition-in-germany-1090930222.html

    GarryB likes this post

    George1
    George1


    Posts : 16893
    Points : 17400
    Join date : 2011-12-22
    Location : Greece

    Russian Medical Development: News - Page 16 Empty Re: Russian Medical Development: News

    Post  George1 Wed Nov 24, 2021 10:18 pm


    Sponsored content


    Russian Medical Development: News - Page 16 Empty Re: Russian Medical Development: News

    Post  Sponsored content


      Current date/time is Thu Dec 02, 2021 6:35 am